27.
Why single-digit-billion-dollar drugs can be unattractive to big pharma
Approval costs can make even billion-dollar markets too small for large pharma portfolios, shaping which diseases get funded
@jefftangx on Backlist
1 appearance on the backlist front page in the last 30 days.